Skip to content
Screener
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$32.49M-28.7%$22.49M-54.6%$50.87M+10.4%$39.78M+243%$45.56M+18.9%
$7K0.0%$7K0.0%$6K-93.4%$7K-95.7%
$10.62M-15.0%$9.97M-1.0%$10.97M-0.7%$11.46M+3.3%$12.5M+20.3%
$27.76M-18.3%$126.15M+67.0%$108.73M+54.2%$79.33M+86.1%$33.99M+9.1%
$107K-79.1%$71K+2,267%$4K-99.4%$128K+2,460%
-$183.65M-7,875%-$17.63M-145%-$4.79M-$19.59M+64.3%$2.36M+138%
$5M+33.3%$5M+33.3%$3.75M0.0%$3.75M0.0%$3.75M0.0%
-$7.22M-1,951%-$3.02M-10.0%-$3M-155%-$2.69M+22.1%-$352K+90.3%
-$163.1M-553%$105.5M+60.7%$100.95M+44.1%$57.05M$36M+68.8%

FAQ

How much cash does Harmony Biosciences Holdings, Inc. generate?
Harmony Biosciences Holdings, Inc. (HRMY) generated $342.0M in operating cash flow over the trailing twelve months.
Where does Harmony Biosciences Holdings, Inc.'s cash flow data come from?
Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.